VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0976838
Sex: F
Age:
State: VT

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20210113; Test Name: fever; Result Unstructured Data: Test Result:39 Centigrade; Comments: 2300: up to 39 C

Allergies:

Symptoms: itching; frontal headache; eye pain on movement; sensitivity to light; arthralgias (wrists, ankles); nausea; chills; fever/chills (up to 39 C); myalgias in the back and contralateral arm; left arm soreness; Redness and swelling at injection site; Redness and swelling at injection site; Lower back pain; This is a spontaneous report from a contactable physician (patient). A 37-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (Lot: EK9231) on 13Jan2021 11:45 at a single dose for covid-19 immunization. Medical history included GERD (gastrooesophageal reflux disease), environmental allergies, Penicillin (but not augmentin) allergies and sulfa allergy. Concomitant medications included cetirizine hydrochloride (ZYRTEC), esomeprazole, and vitamin d. Histrical vaccine included the first dose of BNT162B2 (lot number: EJI685) on 23Dec2020 12:15 in the left arm, for covid-19 immunization. On 13Jan2021 20:00, patient experienced left arm soreness. Then at 21:00, she experienced myalgias in the back and contralateral arm. At 23:00, she had fever/chills (up to 39 C). The next day (14Jan2021) at 2:30, she had frontal headache, eye pain on movement, sensitivity to light, arthralgias (wrists, ankles), persistent fever and nausea. All these symptoms persisted until exactly 11:48 on 14Jan2021, when everything suddenly got better. Still occasional chills but no fever for the rest of the day, left arm pain persists into 15Jan2021. Redness and swelling at injection site are worse. There was also now itching. Lower back pain persists. The outcome of events left arm soreness, "Redness and swelling at injection site" and lower back pain was not recovering. She was recovering from " myalgias in the back and contralateral arm", fever/chills (up to 39 C), frontal headache, eye pain on movement, sensitivity to light, arthralgias (wrists, ankles), nausea, chills Patient did not receive any treatment for the events. No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ESOMEPRAZOLE; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 0976839
Sex: M
Age:
State: NM

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Generalized muscle aches; lethargy; This is a spontaneous report from a contactable physician. A 62-year-old male patient received first (1st) dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EH9899, via an unspecified route of administration in the left arm, on 18Dec2020 12:45 at a SINGLE DOSE for covid-19 immunization. Medical history included hypertension (HTN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medication included hydrochlorothiazide, valsartan (VALSARTAN HCT), amlodipine and aripiprazole (ABILIFY). On 19Dec2020, the patient experienced generalized muscle aches and lethargy. The outcome of events was not recovered. Therapeutic measures were taken as a result of events included OTC motrin and Tylenol. No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.

Other Meds: VALSARTAN HCT; AMLODIPINE; ABILIFY

Current Illness:

ID: 0976841
Sex: M
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/11/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: positive for Covid 19; Test Result: Positive

Allergies:

Symptoms: her husband received the Covid vaccine last Friday and was positive for Covid 19; positive for Covid 19; This is a spontaneous report from a non-contactable consumer reporting for herself and her husband. This case is for the reporter's husband. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number and expiry date not reported) via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine on 08Jan2021 (Friday) and was positive for COVID-19 on 11Jan2021 (Monday). The outcome of the event was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021024045 same reporter/product/event, different patient

Other Meds:

Current Illness:

ID: 0976842
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 01/14/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe dizziness; Nausea; This is a spontaneous report from a contactable consumer (patient) reported a 70-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date not reported), via an unspecified route of administration from an unspecified date, at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient is not pregnant at the time of vaccination. No allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Jan2021 at 14:30, the patient experienced severe dizziness and nausea. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovering. The reporter assessed the events as non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0976843
Sex: F
Age:
State: WI

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: soreness in left arm where injection was given; This is a spontaneous report from a contactable consumer. A 74-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3248), intramuscular (left arm) from 14Jan2021 18:00 to 14Jan2021 18:00 at a single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication included vitamin D3. The patient previously took hydrocodone and had allergy. The patient experienced soreness in left arm where injection was given on 15Jan2021 09:00. The patient did not receive any treatment for the event. The outcome of the event was not recovered.

Other Meds: VITAMIN D3

Current Illness:

ID: 0976844
Sex: F
Age:
State: SC

Vax Date: 01/12/2021
Onset Date: 01/01/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swelling in shot arm; swelling in left side of neck; Facial swelling; The arm, neck, face swelling seemed to be lymphatic; shoulder swelling; This is a spontaneous report from a contactable healthcare professional (patient). A 48-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration in left arm on 12Jan2021 09:45 at single dose for COVID-19 immunization. Medical history included nasal sinus allergies (otherwise healthy), some shellfish sensitivities and mouth swelling with some spices allergy from an unknown date and unknown if ongoing. Concomitant medication included clarithromycin (CLARITIN). The patient previously took codeine and experienced itching reaction. The patient stated, "The night of the vaccine I awoke at 1am with moderate amount of swelling in shot arm, swelling in left side of neck and facial swelling on 13Jan2021 01:15 AM. No breathing problems so I did not go to hospital. Some swelling went down with Benadryl. On the second night, swelling came back in same places with neck/shoulder swelling being worse." The patient called her doctor who set up an appointment for 15Jan2021. Sweeping is some better on the third day have continued to take Benadryl, Motrin seemed to make it worse (as reported). The patient further stated, "My doctor has advised me not to take the second dose of Pfizer COVID 19 vaccine due to the swelling going beyond just arm swelling. The arm, neck, face swelling seemed to be lymphatic." all on 13Jan2021 01:15 AM. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment was given to the patient for the event, over the counter medications - Benadryl and Motrin. The outcome of the events was recovering. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events ware considered non serious as it did not result in death, were not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and were not a congenital anomaly/birth defect. The patient was not pregnant.

Other Meds: CLARITIN [CLARITHROMYCIN]

Current Illness:

ID: 0976845
Sex: F
Age:
State: CA

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swelling and redness and itching at injection site; Swelling and redness and itching at injection site; Swelling and redness and itching at injection site; product=COVID 19, brand=Pfizer, dose 1 administration date: 27Dec2020, dose 2 administration date: 13Jan2021; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 42-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on 13Jan2021 at 17:00 at a single dose for COVID-19 immunization. Relevant medical history included thyroid cancer. The patient has no known allergies. Concomitant medications included thyroid (ARMOR THYROID) and ibuprofen (ADVIL). The patient previously received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: expiry date: unknown) on 27Dec2020 at 10:00 A.M., in the left arm for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. The patient has not been tested for COVID-19 since vaccination. On 14Jan2021 at 09:00 A.M., the patient experienced swelling and redness and itching at injection site. The patient did not receive treatment for the events. Outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds: ARMOUR THYROID; ADVIL

Current Illness:

ID: 0976846
Sex: F
Age:
State: MS

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:99.9; Comments: at highest

Allergies:

Symptoms: arthralgia; fatigue; insomnia; soreness at site of injection; swollen lymph nodes on left anterior clavicular region; Fever (99.9 at highest); chills; first dose was received on 27Dec2020/2nd dose on 13Jan2021; This is a spontaneous report from a contactable healthcare professional (patient). A 44-year-old female received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3302 and expiry date:May2021), via an unspecified route of administration on the left arm on 13Jan2021 13:30 at single dose for covid-19 immunisation. The first dose was received on 27Dec2020 13:30 on the left arm, Medical history included hypertension, anxiety, GERD (gastrooesophageal reflux disease) and insomnia. Concomitant medication included atenolol, omeprazole (PRILOSEC), hydroxyzine hydrochloride (VISTARIL) and unspecified multivitamins. The patient previously took neomycine and experienced drug hypersensitivity. The patient experienced fever (99.9 at highest), chills, arthralgia, fatigue, insomnia, soreness at site of injection, swollen lymph nodes on left anterior clavicular region on 14Jan2021 05:45. No treatment was given for the events. Outcome of the events was recovering. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The reporter considered the events non-serious.

Other Meds: ATENOLOL; PRILOSEC; VISTARIL

Current Illness:

ID: 0976847
Sex: F
Age:
State: NY

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; fever; nausea; headache; body aches; This is a spontaneous report from a contactable nurse (patient). A 25-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), intramuscular on 14Jan2021 13:00 at a single dose on left arm for COVID-19 immunization. The patient medical history was not reported. No allergies to medications, food, or other products. Concomitant medication included linaclotide (LINZESS). The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular on 26Dec2020, 11:00 AM at a single dose on left arm for COVID-19 immunization. The patient experienced chills, fever, nausea, headache, and body aches on 15Jan2021 02:15, after the second dose. No treatment received for the events. The outcome of the events was recovered. The events were considered as non-serious. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was the Hospital. No other vaccines received within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: LINZESS

Current Illness:

ID: 0976848
Sex: U
Age:
State: CA

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Malaise; Febrile; Night sweat; Sore arm; This is a spontaneous report from a contactable consumer. A 60-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 13Jan2021 at a single dose in the right arm for Covid-19 immunization. The patient's medical history was not reported. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included varicella zoster vaccine rge (cho) (SHINGRIX, booster) on 08Jan2021 (within 4 weeks) in the left arm, ibuprofen, acetaminophen and thyroid medicine (unspecified). The vaccination was administered in the hospital. On 14Jan2021 08:00 AM, patient experienced malaise, febrile, night sweat, and sore arm. No treatments were received in response to the events. Since the vaccination, the patient has not been tested for COVID-19. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). The events malaise, febrile, night sweat, and sore arm were recovering at the time of the report. Information on the lot/batch number has been requested.

Other Meds: IBUPROFEN; ACETAMINOPHEN

Current Illness:

ID: 0976849
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: metallic taste in his mouth; This is a spontaneous report from a non-contactable healthcare professional. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced metallic taste in his mouth on an unspecified date. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0976850
Sex: M
Age:
State: NY

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: Temperature; Result Unstructured Data: Test Result:ranged from 101 to 103; Test Date: 20210114; Test Name: Nasal swab; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptoms: Fever/temperature ranged from 101 to 103; chills/severe chills that stayed for two days with tiredness; fatigue; body pains; This is a spontaneous report from a contactable physician (patient). A 33-year-old male received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular on the right arm on 11Jan2021 16:15 at a single dose for covid-19 immunisation. The first dose was received on 24Dec2020 11:00, intramuscular on the left arm. The patient's medical history and concomitant medications were not reported. The night of second dose on 12Jan2021 02:30, patient developed fever, chills, body pains and fatigue. Temperature ranging from 101 to 103, with severe chills that stayed for two days with tiredness. Events was subsided by Tylenol and energy drink. Outcome of the events was recovering. Patient was not diagnosed with COVID-19 prior to vaccination and was tested by nasal swab on 14Jan2021 (pending results) been since the vaccination. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0976851
Sex: F
Age:
State: PA

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: BP; Result Unstructured Data: Test Result:elevated; Test Date: 20210111; Test Name: Body temperature; Result Unstructured Data: Test Result:102.8; Comments: 102.8 (H); Test Date: 20210112; Test Name: Nasal swab; Test Result: Negative ; Comments: Covid test post vaccination

Allergies:

Symptoms: L Axillary lymphadenopathy; Fever 102.8 (H); muscle aches/heaviness; Migraine; Tachycardia; Chest pressure/pain; Chest pressure/pain; elevated BP; malaise; This is a spontaneous report from a contactable 39-year-old female Nurse reported for herself. A 39-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number E10140), intramuscular in arm left on 11Jan2021 12:30 at single dose for COVID-19 immunization. Medical history included Low BP, depression, insomnia, latex allergy. The patient was allergy to morphine and diltiazem (CARDIZEM). The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, E10140) on 24Dec2020 10:45 AM, intramuscular in left arm at age of 39 years old for Covid-19 immunization. Concomitant medication included cefixime (FLEXERIL), diphenhydramine hydrochloride (UNISOM), acetylsalicylic acid (ASPIRIN) and ibuprofen. The patient experienced l axillary lymphadenopathy, fever 102.8, muscle aches/heaviness, migraine, tachycardia, chest pressure/pain, elevated bp, malaise, all on 11Jan2021 23:00 with outcome of recovered with sequelae. The patient underwent lab tests and procedures which included blood pressure: elevated on 11Jan2021, body temperature: 102.8 on 11Jan2021 (H), nasal swab: negative on 12Jan2021 (Covid test post vaccination). The events were non-serious, result in emergency room/department or urgent care. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination. The patient received Bolus of IV (intravenous) fluids for treatment.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds: FLEXERIL; UNISOM; ASPIRIN; IBUPROFEN

Current Illness:

ID: 0976852
Sex: F
Age:
State: AZ

Vax Date: 01/12/2021
Onset Date: 01/01/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sweating; chills; fever; major fatigue; Major hair loss starting 1.5 days following the vaccination; This is a spontaneous report from a contactable other health care professional. A 27-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL0142), intramuscular on 12Jan2021 16:30 at SINGLE DOSE at Arm Left for covid-19 immunisation. Medical history included covid-19; covid prior vaccination: yes. Concomitant medication included escitalopram oxalate (LEXAPRO). Major hair loss starting 1.5 days following the vaccination on an unspecified date in Jan2021, in addition to sweating, chills, fever, and major fatigue on 13Jan2021 22:30. The patient did not receive treatment for the events. The outcome of the events was not recovered.

Other Meds: LEXAPRO

Current Illness:

ID: 0976853
Sex: M
Age:
State: AL

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20210114; Test Name: body temperature; Result Unstructured Data: Test Result:100.5

Allergies:

Symptoms: Onset of fever (100.5); aches; headache; tiredness; muscle pain; chills; joint pain; feeling unwell; This is a spontaneous report from a contactable healthcare professional (patient). A 66-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date unspecified), via an unspecified route of administration on 14Jan2021 at 10:00, at single dose (left arm) for COVID-19 immunization. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient had no allergies to medications, food and/or other products. Concomitant medications included simvastatin and omeprazole (OMEPRAZOL). The patient received simvastatin and omeprazole within 2 weeks of vaccination. On 14Jan2021, at 22:00, the patient experienced onset of fever (100.5) aches, headache, tiredness, muscle pain, chills, joint pain, and was feeling unwell. The patient did not received treatment for the event. Facility where the most recent COVID-19 vaccine was administered was at the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. Outcome of events was not recovered. Information about Lot/Batch has been requested.

Other Meds: SIMVASTATIN; OMEPRAZOL

Current Illness:

ID: 0976854
Sex: M
Age:
State: MA

Vax Date: 12/28/2020
Onset Date: 01/11/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Name: temperature; Result Unstructured Data: Test Result:rising to a maximum of 100 degrees Fahrenheit; Test Name: temperature; Result Unstructured Data: Test Result:temperature back and fort Fahrenheit; Test Name: Oxygen Saturation; Result Unstructured Data: Test Result:good between 95% and 96% %; Test Name: Oxygen Saturation; Test Result: 95 %; Test Date: 20201227; Test Name: Covid test; Test Result: Negative ; Test Date: 20210104; Test Name: Covid test; Test Result: Negative ; Test Date: 20210108; Test Name: Covid test; Test Result: Negative ; Test Date: 20210111; Test Name: Covid test; Test Result: Positive

Allergies:

Symptoms: tested positive for COVID-19; tested positive for COVID-19; This is a spontaneous report from a contactable pharmacist (patient). A 68-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration in left arm on 28Dec2020 at 18:00 at a single dose for COVID-19 immunization. Medical history included diabetic and blood pressure high, both from 10-15 years. There were no concomitant medications. The patient does nursing homes and assisted living facilities and also the employees of the nursing home. The patient received the first dose of COVID-19 vaccine on 28Dec2020 at 1800 PM in the left arm. He tested negative on 27Dec2020, 04Jan2021, and 08Jan2021 and tested positive for COVID-19 on 11Jan2021, which was 2 weeks after the administration of the vaccine. He reported no severe symptoms, all he got from the COVID-19 infection was a little bit of chills, temperatures rising to a maximum of 100 degrees Fahrenheit (temperature back and forth), body aches, oxygen levels at 95%, and no cough. His oxygen saturation has always been good between 95% and 96%. The patient asked what caused the positive test and asked if he was going to have protection after receiving the first dose of COVID vaccine. The patient is due for the second dose of the COVID vaccine on Monday, the 18th (18Jan2021), in which he will still be under isolation. The patient asked if he should wait until he gets out of isolation to receive the second vaccine. The patient asked if that is part of the vaccine to test positive for COVID or if he actually does have COVID. The patient also asked if he can have the second dose. He will be unable to receive second dose of the COVID vaccine at the 21-day mark due to being in isolation from the COVID virus. The patient was recovering from the events. Information on the lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose.

Other Meds:

Current Illness:

ID: 0976855
Sex: F
Age:
State: LA

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm is extremely sore; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A female patient of unknown age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 13Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. On 13Jan2021, she said that her arm is extremely sore. Caller would like to know if she can take Ibuprofen or something that may help with the pain. Outcome was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 0976856
Sex: M
Age:
State: NC

Vax Date: 01/12/2021
Onset Date: 01/01/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: My arm was really sore at the site of injection; Developed body aches similar to the flu; Nauseous; Fatigued; This is a spontaneous report from a contactable consumer. A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 12Jan2021 at a SINGLE DOSE (30mcg) for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose on 23Dec2020. The patient stated, "I received my second vaccine shot on Tuesday, 12Jan2021. On Wednesday (13Jan2021), my arm was really sore at the site of injection and I developed body aches similar to the flu. I was also nauseous and fatigued (Jan2021). Thursday I started to feel better. I am 95% better today on Friday." The outcome of the event was recovering. No follow-up attempts are possible; information about lot/batch number could not be obtained.

Other Meds:

Current Illness:

ID: 0976857
Sex: U
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Unbelievably severe back pain; This is a spontaneous report from a contactable Physician. A patient of unknown gender and age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknow date at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient complained of unbelievably severe back pain that lasted a few days. The patient recovered on unknown date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0976858
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Name: covid; Result Unstructured Data: Test Result:contracted COVID; Comments: contracted COVID after receiving the 1st vaccine dose

Allergies:

Symptoms: contracted covid after receiving the 1st vaccine dose; contracted covid after receiving the 1st vaccine dose; This is Spontaneous report from a contactable nurse. This nurse reported similar events for 6 patients. This is the 3rd of 6 reports. A patient of unspecified age and gender received the first dose of bnt162b2 (Pfizer BioNTech Covid 19 vaccine), via an unspecified route of administration on 22Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient contracted COVID after receiving the 1st vaccine dose on an unspecified date. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose.,Linked Report(s) : US-PFIZER INC-2021035078 same reporter/product/event, different patient;US-PFIZER INC-2021035069 Same reporter/drug, different patient/ event

Other Meds:

Current Illness:

ID: 0976859
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: COVID; COVID; This is spontaneous report from a contactable Nurse. This Nurse reported similar events for 6 patients. This is 5th of six reports. An unknown age and gender patient received 1st of BTN162B2 (Pfizer BioNTech Covid 19 vaccine) on 22Dec2020 at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. it was reported that patient contracted COVID after receiving the 1st vaccine dose. Outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient, who contracted COVID after receiving the 1st vaccine dose, cannot be completely excluded.

Other Meds:

Current Illness:

ID: 0976860
Sex: F
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: shortened of breath; Wheezing; bronchospasm; This is a spontaneous report from a non-contactable nurse. (patient). This 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), from lot El3246 at the left arm on 15Jan2021 12:45 at SINGLE DOSE for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of vaccination.No COVID prior vaccination. Concomitant medications were not reported. On 15Jan2021 17:00, the patient experienced wheezing and shortened of breath. The patient visited physician office for the event and treatment for the events was received, Albuterol for bronchospasm. The events were assessed as non-serious. The patient had not been tested for COVID post vaccination. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 0976861
Sex: F
Age:
State: WA

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe neuralgia pain over 75% of her skin surface; Severe neuralgia pain over 75% of her skin surface; Severe joint pain; Muscle aches; Swollen lymph nodes; Headache; Fatigue; Upper body sporadic shivering; Interval between the first and second doses of BNT162B2 is 27 days; This is a spontaneous report from a contactable nurse (patient). A 39-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3246), via an unspecified route of administration in right arm, on 14Jan2021 at 17:15, at a single dose, for COVID-19 immunization. The patient's medical history included sporadic neuralgia, numbness to patches on legs, shift-work sleep disorder, and generalized anxiety. The patient's concomitant medications included armodafinil (NUVIGIL), paracetamol (TYLENOL), and alprazolam (XANAX). The patient previously took ferric subsulfate (MONSELS Solution) and experienced allergy; and the first dose of BNT162B2 (Lot Number: EH9899) on 18Dec2020 (6 PM) for COVID-19 immunization (in left arm). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 14Jan2021 (05:15 PM), the interval between the first and second doses of BNT162B2 is 27 days. On 15Jan2021 at 9:15 AM, the patient experienced severe neuralgia pain over 75% of her skin surface beginning at 14 hours post-second dose (as reported) and still continuing now at 30 hours post-dose. Also, the patient experienced severe joint pain, muscle aches, swollen lymph nodes, headache, fatigue, and upper body sporadic shivering (not cold). It was unknown if the patient received treatment for the events. The events were considered non-serious. Since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events.

Other Meds: NUVIGIL; TYLENOL; XANAX

Current Illness:

ID: 0976862
Sex: F
Age:
State: FL

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20201120; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Sore injection site, lump and warm; Sore injection site, lump and warm; Sore injection site, lump and warm; This is a spontaneous report from a contactable Other-HCP. A 65-year-old female patient reported that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL12F3), at single dose into the right arm on 14Jan2021 at 01:15 PM for COVID-19 immunization. Medical history was none. The patient had no history of allergies to medications, food, or other products. The patient had a negative Covid test Nasal Swab on 20Nov2020. Concomitant medications included Omeprazole, Atorvastatin, Buspirone, Lisinopril. On 15Jan2021 at 9:00 AM the patient experienced sore injection site, lump and warm. No treatment was received. The events were considered non-serious. The outcome of the events was not recovered.

Other Meds: OMEPRAZOLE; ATORVASTATIN; BUSPIRONE; LISINOPRIL

Current Illness:

ID: 0976863
Sex: F
Age:
State: NY

Vax Date: 01/14/2021
Onset Date: 01/16/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; nausea; This is a spontaneous report from a contactable consumer. A 76-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL3247), via an unspecified route of administration on the left arm on 14Jan2021 15:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included depression and anxiety from an unknown date and unknown if ongoing. Concomitant medication included alprazolam (ALPRAZOLAM), melatonin (MELATONIN), escitalopram (ESCITALOPRAM). The patient experienced headache and nausea on 16Jan2021 19:00. The outcome of the event was recovering.

Other Meds: ALPRAZOLAM; MELATONIN; ESCITALOPRAM

Current Illness:

ID: 0976864
Sex: F
Age:
State: NC

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20201228; Test Name: Heart rate; Result Unstructured Data: Test Result:went to 138; Test Date: 20201228; Test Name: Heart rate; Result Unstructured Data: Test Result:110; Test Date: 20201228; Test Name: Heart rate; Result Unstructured Data: Test Result:Elevated

Allergies:

Symptoms: tunnel vision; 2 minutes after injection Heart rate went to 138/Hr 110/elevated heart rate.; dizziness; This is a spontaneous report from a contactable nurse reporting for herself. A 46-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, Lot number Ek9231, via an unspecified route of administration in left arm on 28Dec2020 at 11:45, at 46 years of age, at single dose for COVID-19 immunization. The patient was not pregnant when she was vaccinated and received the vaccine in Hospital. She didn't receive any other vaccine in the previous 4 weeks. Medical history included Meniere's disease with sudden hearing loss in left ear from an unknown date, gastrooesophageal reflux disease from an unknown date and allergy to penicillin and sulfa drugs. Concomitant medication included famotidine (PEPCID), paracetamol (TYLENOL), ergocalciferol (VITAMIN D) supplements and cetirizine hydrochloride (ZYRTEC). On 28Dec2020, 2 minutes after vaccine injection, the patient experienced tunnel vision, assessed as medically significant, her heart rate went to 138 and she experienced dizziness. The same happened again "at the 8 min mark": heart rate at 110 and dizziness. The events resolved on their own. Dizziness and elevated heart rate happened again later that evening. At the time of the report the reported events had resolved without any treatment.; Sender's Comments: Based on the compatible time association, the events tunnel vision, heart rate increased and dizziness are reasonably related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: PEPCID; TYLENOL; VIT D; ZYRTEC

Current Illness:

ID: 0976865
Sex: F
Age:
State: NY

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: bell's palsy from covid vaccine; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number unknown), at single dose on Jan2021 for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On Jan2021 the patient experienced bell's palsy from COVID-19 vaccine. The event resulted in doctor office/clinic visit, disability or permanent damage. Since the vaccination, the patient has not been tested for COVID-19. At the time of reporting the outcome of the event was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0976866
Sex: M
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program Pfizer First Connect. A male patient of an unspecified age (reported as 72, unknown unit) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm on 15Jan2021. Outcome of the event was unknown. Patient was asking if e was allowed to drink cocktail at night and if the second dose can be administered before or after 21 days. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0976867
Sex: M
Age:
State: NY

Vax Date: 12/28/2020
Onset Date: 01/10/2021
Rec V Date: 01/27/2021
Hospital: Y

Lab Data: Test Date: 20210113; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: Pressured Speech; Weakness and tremors to both limbs; Weakness and tremors to both limbs; muscle spasm; This is a spontaneous report from a contactable Other HCP (patient). This 49-year-old male patient received his first dose of intramuscular BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 28Dec202 at 17:30 in left arm at single dose for COVID-19 immunisation at the age of 49-year-old. Lot number was EK9231. Medical history included gout. Concomitant medications were unknown. On 10Jan2021, the patient experienced Pressured Speech, weakness and tremors to both limbs and muscle spasm. The events resulted in Emergency room/ department or urgent care and Hospitalization for one day. The patient was not treated for the events. COVID was tested post vaccination on 13Jan2021, Nasal Swab, polymerase chain reaction (PCR) and it resulted negative. The patient did not recover from the events.; Sender's Comments: The events pressured speech, weakness and tremors to both limbs ,muscle spasm are less likely related to suspect BNT162B2 administration given the weak time association. The available examination results would be helpful for further assessment. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0976868
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: My hips are killing me/I am having difficulty sleeping due to this; My hips are killing me/I am having difficulty sleeping due to this; I was not feeling comfortable; My back, knees and ankles were also hurting me; knees and ankles were also hurting me; This is a spontaneous report from a contactable nurse and a contactable physician. A male patient of an unspecified age receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was administered the second dose of Pfizer vaccine on Thursday. Unlike the first dose, the second one had adverse events. The patient stated, 'My hips are killing me, I am having difficulty sleeping due to this. I was not feeling comfortable. My back, knees and ankles were also hurting me' on an unspecified date. It was also stated that many of his colleagues had similar experiences. The outcome of the events was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0976869
Sex: F
Age:
State: MA

Vax Date: 01/02/2021
Onset Date: 01/02/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; This is a spontaneous report from a contactable pharmacist reporting for herself. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a sore arm for about 2 hours after receiving the first dose of COVID-19 vaccine on 02Jan2021. The outcome of the event was unknown. Information of lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0976870
Sex: M
Age:
State:

Vax Date: 01/11/2021
Onset Date:
Rec V Date: 01/27/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: It affected him neurologically and he can't walk, nor stand without wanting to vomit.; It affected him neurologically and he can't walk, nor stand without wanting to vomit.; It affected him neurologically and he can't walk, nor stand without wanting to vomit.; It affected him neurologically and he can't walk, nor stand without wanting to vomit.; This is a spontaneous report from a non-contactable consumer (patient's wife) A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 11Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was hospitalized on 12Jan2021 and reported that on unspecified date "affected him neurologically and he can not walk, nor stand without wanting to vomit. Everything, and I mean everything else has been ruled out". Events outcome were unknown. The action taken was not applicable. No follow-up attempts are possible; Information about batch/lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0976871
Sex: F
Age:
State: TX

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Name: Blood Pressure; Result Unstructured Data: Test Result:increased; Test Name: Pulse rate; Result Unstructured Data: Test Result:increased

Allergies:

Symptoms: 1st 24hrs= Rt (right) side Facial, cheek, jaw, swelling; 1st 24hrs= Rt (right) side Facial, cheek, jaw, swelling, numbness, tingling. Begin of Rt (right) eye pain, tingling, Rt (right) eye lower lid internal tenderness, softness, sensitivity to touch; 1st 24hrs= Rt (right) side Facial, cheek, jaw, swelling, numbness, tingling. Begin of Rt (right) eye pain, tingling, Rt (right) eye lower lid internal tenderness, softness, sensitivity to touch; 1st 24hrs= Rt (right) side Facial, cheek, jaw, swelling, numbness, tingling. Begin of Rt (right) eye pain, tingling, Rt (right) eye lower lid internal tenderness, softness, sensitivity to touch; 1st 24hrs= Rt (right) side Facial, cheek, jaw, swelling, numbness, tingling. Begin of Rt (right) eye pain, tingling, Rt (right) eye lower lid internal tenderness, softness, sensitivity to touch; 1st 24hrs= Rt (right) side Facial, cheek, jaw, swelling, numbness, tingling. Begin of Rt (right) eye pain, tingling, Rt (right) eye lower lid internal tenderness, softness, sensitivity to touch; eye lower lid internal tenderness; Behind lower Rt (right) ear pain, Rt (right) sided neck pain, Rt (right) side buttocks pain, Rt (right) side thigh pain, swelling, Rt (right) knee pain, and swelling; Behind lower Rt (right) ear pain, Rt (right) sided neck pain, Rt (right) side buttocks pain, Rt (right) side thigh pain, swelling, Rt (right) knee pain, and swelling; Behind lower Rt (right) ear pain, Rt (right) sided neck pain, Rt (right) side buttocks pain, Rt (right) side thigh pain, swelling, Rt (right) knee pain, and swelling; Behind lower Rt (right) ear pain, Rt (right) sided neck pain, Rt (right) side buttocks pain, Rt (right) side thigh pain, swelling, Rt (right) knee pain, and swelling; Behind lower Rt (right) ear pain, Rt (right) sided neck pain, Rt (right) side buttocks pain, Rt (right) side thigh pain, swelling, Rt (right) knee pain, and swelling; Behind lower Rt (right) ear pain, Rt (right) sided neck pain, Rt (right) side buttocks pain, Rt (right) side thigh pain, swelling, Rt (right) knee pain, and swelling; Dizziness; sleepiness; increased blood pressure and pulse; increased blood pressure and pulse; Then sleeplessness till 4am next day; This is a spontaneous report from a contactable Nurse A 43-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration on 15Jan2021 14:45 at single dose for covid-19 immunisation. Vaccine location was right arm. Medical history included attention deficit hyperactivity disorder from an unknown date, hypothyroidism from an unknown date. The patient's concomitant medications were not reported. The patient previously took cipro [ciprofloxacin] and experienced drug hypersensitivity. The patient experienced 1st 24hrs= Rt (right) side Facial, cheek, jaw, swelling, numbness, tingling. Begin of Rt (right) eye pain, tingling, Rt (right) eye lower lid internal tenderness, softness, sensitivity to touch on 15Jan2021 15:15 with outcome of not recovered, behind lower rt (right) ear pain, rt (right) sided neck pain, rt (right) side buttocks pain, rt (right) side thigh pain, swelling, rt (right) knee pain, and swelling on 15Jan2021 15:15 with outcome of not recovered, dizziness on 15Jan2021 15:15 with outcome of not recovered, sleepiness on 15Jan2021 15:15 with outcome of not recovered, increased blood pressure and pulse on 15Jan2021 15:15 with outcome of not recovered, then sleeplessness till 4am next day (as reported) on 15Jan2021 15:15 with outcome of not recovered. Information on the lot/batch number has been requested.; Sender's Comments: Based on the time association, the possible contribution of suspect BNT162B2 to the events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0976872
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; body aches; This is a spontaneous report from a contactable consumer via Pfizer Sales Representative. A 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on an unknown date at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. Historical vaccination included first dose of BNT162B2 on an unknown date at single dose for COVID-19 immunisation. Patient had chills and body aches after receiving second dose. Outcome was unknown. No follow-up attempts are possible; Information about Lot/Batch cannot be obtained.

Other Meds:

Current Illness:

ID: 0976873
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; arm pain; This is a spontaneous report from a contactable nurse (patient) via Pfizer Sales Representative. A female patient of unspecified age received first dose of BNT162B2, via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced headache and arm pain on an unspecified date. The outcome of the events was unknown. Information on Lot/ Batch number has been requested.

Other Meds:

Current Illness:

ID: 0976874
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: white spots forming on arm post vaccine injection; This is a spontaneous report from a contactable Pharmacist (patient) via a manufacturer sales representative. A patient of unknown age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on an unknown date at single dose for COVID-19 immunisation. Medical history and concomitant medications were none. The patient complains of white spots forming on arm post vaccine injection of first dose. Outcome was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0976875
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe cramping; really bad period after receiving vaccine; This is a spontaneous report received from a non-contactable consumer via a Pfizer sales representative. A female patient of an unspecified age received the first dose of BNT162B2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date: unknown), via an unspecified route of administration, on 29Dec2020, at single dose, for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included an unspecified birth control that takes away her period, she has been on it for 2+ years. The patient experienced severe cramping and really bad period on an unspecified date after receiving vaccine 15 days ago. The outcome of the events was unknown. The patient thinks the events are correlated to the vaccine. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0976876
Sex: F
Age:
State: IL

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache and body aches for 24 hours; Headache and body aches for 24 hours; edema left arm pit and left collarbone and neck; edema left arm pit and left collarbone and neck; tingling down the back of neck to shoulder blade for 1 week; All left side, pain at injection site with warm to touch for three days; All left side, pain at injection site with warm to touch for three days; This is a spontaneous report from a contactable nurse (patient). A 64-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, LOT# EL1283), via intramuscular in left arm on 08Jan2021 13:15 at second single dose for covid-19 immunization. Medical history included diabetes type 2, allergies. Concomitant medication included metformin, simvastatin, semaglutide (RYBELSUS). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose BNT162B2 (LOT# EL1685) on 20Dec2020 01:15 PM, via intramuscular in left arm for Covid-19 immunization. The patient experienced headache and body aches for 24 hours, edema under left arm pit and left collarbone and neck with tingling down the back of neck to shoulder blade for 1 week. All left side, pain at injection site with warm to touch for three days. Adverse event start date/time: 09Jan2021 06:00 AM. Events were considered as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse events. Outcome of the events was recovering.

Other Meds: METFORMIN; SIMVASTATIN; RYBELSUS

Current Illness:

ID: 0976877
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/15/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Left arm soreness and tenderness; This is a spontaneous report from a non-contactable consumer reported for herself. A 24-year-old female patient (no pregnant at the time of vaccination) received her 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 3302) at single dose via an unknown route at left arm on an unknown date for Covid-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced left arm soreness and tenderness on 15Jan2021. The event was reported as not serious. No treatment received for the adverse event. Outcome of the event was resolved. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0976878
Sex: F
Age:
State: FL

Vax Date: 01/08/2021
Onset Date: 01/15/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20210115; Test Name: Body temperature; Result Unstructured Data: Test Result:99.7; Comments: at 18:00 PM, fever

Allergies:

Symptoms: Severe headache; tiredness; muscle pain; chills; fever 99.7; joint pain; feeling unwell; cough; no appetite; This is a spontaneous report from a contactable consumer reported for self. This 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL3246) via unspecified route of administration at 08Jan2021 10:30 AM at single dose in right arm for COVID-19 immunization. The patient is not pregnant. The age at vaccination is reported as 74 years old. The patient medical history and concomitant medications were not reported. The patient previously received benzoin and experienced allergy. The patient experienced severe headache, tiredness, muscle pain, chills, fever 99.7, joint pain, feeling unwell, cough, no appetite at 15Jan2021 18:00 PM. The events are reported as non-serious by reporter. The patient received no treatment. The patient was not diagnosed with COVID-19 prior to and since the vaccination. The patient was recovering from the events.

Other Meds:

Current Illness:

ID: 0976879
Sex: U
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:103 degrees

Allergies:

Symptoms: fever of 103 degrees; major flu symptoms; This is a spontaneous report from a contactable physician received via a manufacturer sales representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient had a major flu symptoms including a fever of 103 degrees after receiving the shot on an unknown date. Outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0976880
Sex: F
Age:
State: CA

Vax Date: 12/01/2020
Onset Date: 12/01/2020
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: mild flu symptoms for 24 hours.; This is a spontaneous report from a contactable physician via Pfizer sales representative. A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Dec2020 (reported as 3 weeks ago) at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced mild flu symptoms for 24 hours in Dec2020. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0976881
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 01/02/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: acute vertigo/most likely benign paroxysmal positional vertigo; This is a spontaneous report from a contactable physician (patient). A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly, on 22Dec2020 at a single dose (reported as 0.3) for COVID-19 immunization. The patient had no medical history or concomitant medications. The patient experienced acute vertigo/most likely benign paroxysmal positional vertigo on 02Jan2021, which was reported as medically significant. The patient could barely get out of bed on 02Jan2021. The clinical course was reported as follows: The patient did not have any systemic symptoms after receiving the first vaccine but 12 days (as reported) after, she did have some acute vertigo; reported as very serious for her. She could barely get out of bed the first couple of days after getting it. The patient went to ear-nose-and throat (ENT) because she wanted to determine the likelihood of the vertigo having anything to do with her getting the vaccine before she got her second vaccine. She was told it was most likely benign paroxysmal positional vertigo, most likely positional, had nothing to do with the vaccine, and that she was okay to go ahead and get her second vaccine. The vertigo went away within a couple of days. The patient clarified that by 06Jan2021, she was feeling much better and recovered completely. The clinical outcome of acute vertigo/most likely benign paroxysmal positional vertigo and barely get out of bed was recovered on 06Jan2021. The batch/lot number for the vaccine, BNT162B2, was not provided and has been requested during follow up.; Sender's Comments: The reported acute vertigo/most likely benign paroxysmal positional vertigo occurred 12 days after the first dose of COVID 19 vaccine, BNT162B2, is considered an intercurrent disease, unlikely related to BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.

Other Meds:

Current Illness:

ID: 0976882
Sex: F
Age:
State: WI

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dyspnea; myalgias; chest pain/Chest pain is moderately severe and worse with deep inspiration; back aches; feeling clammy; This is a spontaneous report from a contactable pharmacist. A 37-year-old female patient received 2nd dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL3248, expiration date unspecified), via an unspecified route of administration on 11Jan2021 12:00 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 on 21Dec2020 and experienced fever, chills, myalgias, and some sensory changes to the left arm; and vancomycin and experienced allergies. On 11Jan2021, the patient experienced dyspnea and myalgias following her second vaccination today. It was reported that she received the second dose of the vaccine around noon and then began having dyspnea and chest pain around an hour later. Chest pain was moderately severe and worse with deep inspiration. Patient was also having back aches and was feeling clammy. Patient represented to the vaccine site and was brought to the emergency room department/urgent care for evaluation. Patient denied any history of vaccine associated reactions. The patient received therapy for the events which included acetaminophen, ketorolac and intravenous (IV) fluids. The patient had no other vaccine in four weeks. Outcome of events was unknown.; Sender's Comments: Based on the time association, the events are possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0976883
Sex: F
Age:
State: TN

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: mild metallic taste; poor administration tech; extreme burning for 10 min following vax-I; arm soreness; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730), via an unspecified route of administration on 21Dec2020 11:30 at single dose for covid-19 immunization. Vaccine location was left arm and it was the first dose. Patient is not pregnant. The facility type vaccine was Workplace clinic. Medical history included obesity from an unknown date. Known allergies included sulfa and penicillin. Concomitant medication included metoprolol, vitamin d3, calcium, probiotics. Patient was not diagnosed with COVID-19 prior to vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced mild metallic taste on 22Dec2020 11:30 with outcome of recovered, arm soreness on 21Dec2020 with outcome of recovered, poor administration tech on 21Dec2020 11:40 with outcome of recovered, extreme burning for 10 min following vax-i on 21Dec2020 11:40 with outcome of recovered. The verbatim as follow: 1st Vax: mild metallic taste and arm soreness (including extreme burning for 10 min following vax-I believe this was poor administration tech), slight metallic taste 24 hrs post vax, lasted a few hours. Patient didn't receive treatment for the adverse events. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 04Jan2021. The covid test type post vaccination was Nasal Swab. The covid test name post vaccination was PCR.

Other Meds: METOPROLOL; VITAMIN D3; CALCIUM; PROBIOTICS

Current Illness:

ID: 0976884
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; low grade fever; extreme fatigue; headache; newmuscle pain; joint pain; weakness; This is a spontaneous report from a non-contactable other HCP(patient). A 26-years-old male patient received second dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine, lot number EJ1686), via an unspecified route of administration at Arm Left on an unknown date at single dose for COVID-19 immunization. The medical history included Asthma, eczema, Sulfonamides allergy , cephalosporins allergy, penicillin allergy. The concomitant medications were montelukast, sertraline. The patient previously took azithromycin and experienced allergy. The Historical Vaccine was first dose BNT162B2 for COVID-19 immunization. The patient experienced Chills, low grade fever, extreme fatigue, headache, new muscle pain, joint pain and weakness on an unknown date. The symptoms occurred 8 hours after receiving injection. There was no treatment received for all the events. There was no other vaccine in four weeks. There was no COVID prior vaccination. There was no COVID tested post vaccination. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: MONTELUKAST; SERTRALINE

Current Illness:

ID: 0976885
Sex: F
Age:
State: TN

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: Covid PCR; Test Result: Negative ; Test Date: 20210104; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: frequent urination; sudden extreme fatigue; headache/headache began receding from the front to back of head and down back of neck; sore injection site; heavy metallic taste; no appetite; This is a spontaneous report from a contactable nurse (patient). A 55-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration on 11Jan2021 08:30 at single dose in right arm for COVID-19 immunization. The patient medical history included obesity and known allergies to sulfa and penicillin. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), via an unspecified route of administration on 21Dec2020 11:30 at single dose in left arm for COVID-19 immunization and experienced mild metallic taste and arm soreness (including extreme burning for 10 min following vaccination, the patient believe this was poor administration tech), slight metallic taste 24 hrs post vaccination, lasted a few hours. Concomitant medications in two weeks included metoprolol, colecalciferol (VIT D3), Calcium, ascorbic acid (C) and probiotic. The patient had no covid prior vaccination. It was reported that after the second vaccination, the patient had no burning at site, on 11Jan2021 09:30 the patient had heavy metallic taste approximate 40 mins post vaccine and lasted approximate 12 hrs, at 12 hrs post vaccine (on 11Jan2021 20:30) sudden extreme fatigue, 15 hrs post vaccine (on 11Jan2021 23:30) frequent urination began and lasted approximate 18 hrs. The patient woke up with headache 6/10 that medication would not touch, no appetite but ate and drank anyway hoping would help with headache (it didn't) (reported on 11Jan2021 09:30), approximate 32 hrs post vax headache began receding from the front to back of head and down back of neck. Slept well and woke up 48 hrs post vax feeling normal but with sore injection site (reported as on 11Jan2021 09:30). The patient underwent lab tests and procedures related to covid included nasal swab and PCR with negative result on 04Jan2021. No treatment was received for the events. The outcome of the events was recovered in Jan2021.

Other Meds: METOPROLOL; VIT D3; CALCIUM; C [ASCORBIC ACID]; PROBIOTICS

Current Illness:

ID: 0976886
Sex: F
Age:
State: WI

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Name: influenza A and B; Result Unstructured Data: Test Result:Unknown Results; Test Date: 20210111; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Also having brain fog; extreme fatigue; intermittent nausea; headache; I have had a headache since receiving the vaccine that interferes with my daily activities; This is a spontaneous report from a contactable physician (patient). A 32-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EK 5730), via an unspecified route of administration on left arm at 11:00 AM on 29Dec2020 at single dose for COVID-19 immunization. Medical history included migraine and known allergies: penicillin. Concomitant medication included bupropion. The patient did not receive other-vaccine-in-four weeks. The patient had a headache since receiving the vaccine that interferes with her daily activities. Headache not improved with OTC medications. Also having brain fog, extreme fatigue and intermittent nausea, all at 17:00 on 29Dec2020. Events resulted-in doctor or other healthcare professional office/clinic visit. The patient tested COVID post-vaccination with type nasal swab on 11Jan2021, result: Negative., and influenza A and B on unknown date without result. The patient received OTC medications for event headache, not received any treatment for other events. The outcome of events was not recovered.

Other Meds: BUPROPION

Current Illness:

ID: 0976887
Sex: M
Age:
State:

Vax Date: 12/24/2020
Onset Date: 12/25/2020
Rec V Date: 01/27/2021
Hospital:

Lab Data: Test Date: 20201225; Test Name: fever; Result Unstructured Data: Test Result:fever

Allergies:

Symptoms: On day after of vaccine had fever; chills; headache; sore arm; This is a spontaneous report from a non-contactable other HCP. A 24-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number=EH9899), via an unspecified route of administration on 24Dec2020 07:00 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Other medications in two weeks was no. On day after of vaccine had fever, chills, as well as headache, and sore arm on 25Dec2020. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0976888
Sex: F
Age:
State: NY

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 01/27/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Small rash to left arm; This is a spontaneous report from a contactable nurse (patient). A 36-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number Eks730, expiration date unspecified), via an unspecified route of administration on 23Dec2020, at 08:00 at single dose (left arm) for COVID-19 immunization. Medical history included COVID-19. The patient had no known allergies. The patient's concomitant medications were not reported. On 24Dec2020, at 07:00, the patient experienced small rash to left arm. There was no treatment for the event. The patient had no other medications in 2 weeks. It was reported that the patient had Covid prior vaccination and patient was not Covid tested post vaccination. Outcome of event was recovered on an unspecified date.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm